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Non-melanoma skin cancer (NMSC) has been associated with several other 
conditions, including melanoma and non-Hodgkin’s lymphoma (Hjalgri et 
al., 2000; Hu et al., 2005). In addition, the risk of NMSC has been found to be 
greater in various chronic disease groups (Frisch et al., 1996; Frisch and Melbye, 
1995). It is uncertain whether this association is related to the treatments for 
those chronic diseases (such as radiation therapy or immunosuppressant 
therapy) rather than the disease itself (Saladi and Persaud, 2005; Karagas et al., 
2001). Moreover, using a Danish nationwide cohort of patients with NMSC, 
Jensen et al. (2006) found a lower mortality in basal cell carcinoma (BCC) 
patients compared with the general population, reflecting what the authors 
suggested to be a selection bias to that data set.
In a follow-up study utilizing a nationwide Danish patient registry linked 
to the nationwide cohort of patients with NMSC, the researchers attempted to analyze the development of NMSC in 
patients hospitalized for various chronic diseases (Jensen et al., 2008). To control for potential surveillance bias, they 
also evaluated the severity of NMSC diagnosed. Several chronic diseases were associated with increased incidence 
of NMSC, including an association between BCC and transplantation as well as lymphoma. The risk of squamous cell 
carcinoma was found to be higher in patients previously hospitalized for leukemia as well as other skin diseases.
Through the following questions, we examine this paper in greater detail. For brief answers, please refer to http://
network.nature.com/group/jidclub.
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QUESTIONS
1. Why would patients with other conditions be at risk for skin cancer?
2. What is the Charlson index, and how was it used in this study?
3. How did the investigators control for potential bias in this study?
4. What were the major findings of this study?
5. How did the investigators explain their findings?
6. What may be the clinical implications of this article?
7. What future studies would help confirm these hypothesis-generating results?
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